|
| 37871798 | Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study. | Am J Transplant | 2024 |
| 37793170 | Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and Disparity. | J Infect Dis | 2024 |
| 34973459 | A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection. | Clin Gastroenterol Hepatol | 2023 |
| 37744732 | Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV. | J Virus Erad | 2023 |
| 37478909 | Is neighborhood deprivation index a risk factor for Staphylococcus aureus infections? | Am J Infect Control | 2023 |
| 37740989 | Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes. | Int J Drug Policy | 2023 |
| 37579209 | Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations. | Clin Infect Dis | 2023 |
| 37733308 | Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19. | N Engl J Med | 2023 |
| 35770681 | HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy. | Hepatology | 2023 |
| 35578388 | A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use. | HIV Med | 2023 |
| 37278302 | Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia. | J Viral Hepat | 2023 |
| 37435958 | Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank. | Clin Infect Dis | 2023 |
| 37001945 | Chronic Hepatitis C: Advances in Therapy and the Remaining Challenges. | Med Clin North Am | 2023 |
| 37129258 | Hepatitis B e Antigen-Negative Single Hepatocyte Analysis Shows Transcriptional Silencing and Slow Decay of Infected Cells With Treatment. | J Infect Dis | 2023 |
| 36856472 | Hepatitis D virus infection: Progress on the path toward disease control and cure. | J Viral Hepat | 2023 |
| 36722133 | Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus. | J Infect Dis | 2023 |
| 36694361 | Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment. | Clin Infect Dis | 2023 |
| 36441638 | Evaluation of a pilot emergency department linkage to care program for patients previously diagnosed with Hepatitis C. | J Viral Hepat | 2023 |
| 36633838 | Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. | JAMA | 2023 |
| 36049028 | Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV). | Clin Infect Dis | 2023 |
| 33069882 | Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. | Clin Gastroenterol Hepatol | 2022 |
| 35797115 | Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment. | J Clin Invest | 2022 |
| 35697332 | Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection. | J Hepatol | 2022 |
| 35460726 | Safety and efficacy of vebicorvir in virologically suppressed patients with chronic hepatitis B virus infection. | J Hepatol | 2022 |
| 36561174 | Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial. | medRxiv | 2022 |
| 36269852 | Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. | JAMA | 2022 |
| 36302828 | Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection. | Sci Rep | 2022 |
| 36299427 | Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial. | medRxiv | 2022 |
| 33559089 | Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults. | Dig Dis Sci | 2022 |
| 35217092 | Clostridioides difficile infection (CDI) in a previous room occupant predicts CDI in subsequent room occupants across different hospital settings. | Am J Infect Control | 2022 |
| 35034373 | Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis. | Hepatology | 2022 |
| 35026142 | A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. | Lancet Gastroenterol Hepatol | 2022 |
| 35235245 | Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment. | Aliment Pharmacol Ther | 2022 |
| 34699587 | Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments. | Clin Infect Dis | 2022 |
| 34698347 | Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. | Clin Infect Dis | 2022 |
| 34808487 | Validation of a tool to assess effectiveness of peer-recruitment for hepatitis C testing and linkage to care among people who inject drugs. | Drug Alcohol Depend | 2022 |
| 34543417 | Nonadherence to Ledipasvir/Sofosbuvir Did Not Predict Sustained Virologic Response in a Randomized Controlled Trial of Human Immunodeficiency Virus/Hepatitis C Virus Coinfected Persons Who Use Drugs. | J Infect Dis | 2022 |
| 32894697 | Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study. | Ann Intern Med | 2021 |
| 35559126 | Impact of Co-occurring Drug Use, Hazardous Alcohol Use, and Mental Health Disorders on Drug Use Patterns in People With HIV and Hepatitis C Virus Infection. | Open Forum Infect Dis | 2021 |
| 33743541 | A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. | Hepatology | 2021 |
| 33880389 | T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy. | Open Forum Infect Dis | 2021 |
| 33837975 | Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis. | Alcohol Clin Exp Res | 2021 |
| 34924891 | Minimal Monitoring of Treatment for Hepatitis C Virus Infection. | Gastroenterol Hepatol (N Y) | 2021 |
| 34704194 | Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019. | Adv Ther | 2021 |
| 34549060 | Hepatitis B Virus/Hepatitis D Virus-Coinfected Liver Transplant Candidate Receiving Hepatitis B Virus-Deoxyribonucleic Acid-Positive Allograft and Treated With High-Dose Hepatitis B Immune Globulin. | ACG Case Rep J | 2021 |
| 34740020 | HCV communication within ego-centric networks of men and women who inject drugs. | Drug Alcohol Depend | 2021 |
| 34255381 | A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. | Hepatology | 2021 |
| 33145648 | Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis C. | Adv Ther | 2021 |
| 33277801 | Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant. | Am J Transplant | 2021 |
| 33160152 | Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration. | Int J Drug Policy | 2021 |